Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: A double-blind randomised controlled trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 119, Issue 8, 2012, Pages 975-986

  Bellad, M B ^a   Tara, D ^a   Ganachari, M S ^b   Mallapur, M D ^a   Goudar, S S ^a   Kodkany, B S ^a   Sloan, N L ^c   Derman, R ^c  

^a JAWAHARLAL NEHRU MEDICAL COLLEGE   (India)

^b K L E S S COLLEGE OF PHARMACY   (India)

^c CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

Haemoglobin; misoprostol; oxytocin; postpartum blood loss

Indexed keywords

HEMOGLOBIN; MISOPROSTOL; OXYTOCIN; PLACEBO;

ADULT; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FEVER; HUMAN; LABOR; MAJOR CLINICAL STUDY; NAUSEA; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STUDENT T TEST; TREATMENT OUTCOME; VOMITING; AWARENESS; CLINICAL PROTOCOL; CLINICAL RESEARCH; DRUG EFFICACY; EDITOR; LABOR STAGE 3; MEDICAL ETHICS; MEDICAL LITERATURE; NOTE; PEER REVIEW; PREGNANT WOMAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED STATES;

EID: 84862534456     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2012.03341.x     Document Type: Article

References (37)

1. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA,. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-74.
2. WHO, UNICEF, UNFPA, The World Bank. Maternal mortality in 2005: estimates developed by WHO, UNICEF, UNFPA, and the World Bank. In: World Health Organization, editor. WHO Press, World Health Organization. Geneva: World Health Organization; 2005. pp. 16-7, 23- 27, 29- 38.
3. Sloan NL, Durocher J, Aldrich T, et al., What measured blood loss tells us about postpartum bleeding: a systematic review. Br J Obstet Gynaecol 2010; 117: 788-800.
4. WHO, UNFPA, UNICEF, World Bank. Reduction of maternal mortality, a joint WHO/UNFPA/UNICEF/World Bank Statement. World Health Organization. Geneva: World Health Organization; 1999.
5. Brabin BJ, Hakimi M, Pelletier D,. An analysis of anemia and pregnancy-related maternal mortality. J Nutr 2001; 131: 604-14.
6. Bharati P, Som S, Chakrabarty S, et al., Prevalence of anemia and its determinants among nonpregnant and pregnant women in India. Asia Pac J Public Health 2008; 20: 347-59.
7. El-Refaey H, O'Brien P, Morafa W, et al., Misoprostol for the third stage of labour. Lancet 1996; 347: 1257.
8. Senior J, Marshall K, Sangha R, Clayton JK,. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br J Pharmacol 1993; 108: 501-6.
9. Tang OS, Schweer H, Seyberth HW,. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002 17: 332-336.
10. Tang OS, Ho PC,. The pharmacokinetics and different regimens of misoprostol in early first- trimester medical abortion. Contraception 2006; 74: 26-30.
11. Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ,. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2007;3: CD000494. DOI:.
12. Langebach C,. Misoprostol in preventing postpartum haemorrhage: a meta-analysis. Int J Gynoecal Obstet 2006; 92: 10-8.
13. Winikoff B, Dabash R, Durocher J, et al., Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet 2010; 16: 375.
14. Walley RL, Wilson JB, Crane JM, et al., A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour. BJOG 2000; 107: 1111-5.
15. Høj L, Cardoso P, Nielsen BB, et al., Effect of sublingual misoprostol on severe postpartum hemorrhage in a primary health centre in Guinea-Bissau: randomized double blind clinical trial. Br Med J 2005; 331: 723-7.
16. Bugalho A, Daniel A, Faundes A, Cunha M,. Misoprostol for prevention of postpartum hemorrhage. Int J Gynecol Obstet 2001; 73: 1-6.
17. Derman RJ, Kodkany BS, Goudar SS,. Oral misoprostol in preventing postpartum hemorrhage in resource-poor communities: a randomized controlled trial. Lancet 2006; 368: 1248-1253.
18. Walraven G, Blum J, Dampha Y, et al., Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. Br J Obstet Gynaecol 2005; 12: 1277-83.
19. Parker KL, Schimmer BP,. Pituitary hormones and their hypothalamic releasing hormones. In:, Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman: The pharmacologic basis of therapeutics. 11th edn. New York: McGraw-Hill, 2006, 1489-1510.
20. Amico JA, Seitchik J, Robinson AG,. Studies of oxytocin in plasma of women during hypocontractile labor, J Clin Endocrinol Metab 1984; 58: 274-9.
21. Hofmeyr GJ, Nikodem VC, de Jager M, Drakely A,. Side-effects of oral misoprostol in the third stage of labour-a randomised placebo-controlled trial. S Afr Med J 2001; 91: 432-5.
22. Hofmeyr GJ, Gülmezoglu AM,. Misoprostol for the prevention and treatment of postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008; 22: 1025-41.
23. WHO Department of Reproductive Health Research. WHO statement regarding the use of misoprostol for postpartum haemorrhage prevention and treatment. Geneva: World Health Organization, 2009.
24. Durocher J, Bynum J, León W, et al., High fever following postpartum administration of sublingual misoprostol. Br J Obstet Gynaecol 2010; 117: 845-52.
25. Khan RU, El-Rafaey H,. Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor. Obstet Gynecol 2003; 101: 968-74.
26. Vimala N, Mittal S, Kumar S,. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section. Int J Gynaecol Obstet 2006; 92: 106-10.
27. Singh G, Radhakrishnan G, Guleria K,. Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor. Int J Gynaecol Obstet 2009; 107: 130-4.
28. Blum J, Winikoff B, Raghavan S, et al., Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Lancet 2010; 375: 217-23.
29. Creinin MD, Carbonell JL, Schwartz JL, et al., A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion. Contraception 1999; 59: 11-6.
30. Bellad M, D T, Ganachari M, Mallapur M,. Sublingual (SL) powdered misoprostol (400 mcg) vs IM oxytocin (10 IU) for prevention of postpartum blood loss-a randomized controlled trial. Int J Gynecol Obstet 2009; 107: S124-5.
31. Weeks AD, Alia G, Vernon G, et al., Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial. Lancet 2010; 9: 375 Epub 2009 Dec 7.
32. Abdel-Aleem H, Singata M, Abdel-Aleem M, et al., Uterine massage to reduce postpartum hemorrhage after vaginal delivery. Int J Gynaecol Obstet 2010; 111: 32-6.
33. Hofmeyr GJ, Nikodem VC, de Jager M, Gelbart BR,. A randomised placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol 1998; 105: 971-5.
34. Gülmezoglu AM, Villar J, Ngoc NTN, et al., WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001; 358: 689-95.
35. Penaranda W, Arrieta O, Yances B,. Active mangement of the childbirth with sublingual misoprostol: a clinical controlled trial in the Hospital de Maternidad Rafael Calvo [Manjeo activo del alumbramiento con misoprostol sublingual: un estudio clinico controlado en el Hospital de Maternidad Rafael Calvo de Cartagena]. Rev Colomb Obstet y Gineco 2002; 53: 87-92.
36. Vimala N, Mittal S, Kumar S, et al., Sublingual misoprostol versus methylergometrine for active management of the third stage of labor. Int J Gynaecol Obstet 2004; 87: 1-5.
37. Lam H, Tang O, Lee CP, Ho PC,. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor. Acta Obstet Gynecol Scand 2004; 83: 647-50.